AngioDynamics News and Activities
Presence
AngioDynamics makes medical devices for minimally invasive treatment. Its products include vascular access, cancer treatment, and surgery support tools for hospitals, clinics, and healthcare professionals.
AngioDynamics products and services overview:
- Vascular access
- Cancer treatment
- Drainage products
- Surgical devices
- Imaging support
- Circulatory support
Revenue: ~$291 million
Employees: 900
Headquarters: Latham, United States (USA)
AngioDynamics is one of the...
AngioDynamics is a company listed under the stock ticker ANGO (US).
Executives
View the org chart displaying its 31 main executives
Most searched biographies at AngioDynamics
- James Clemmer, President and Chief Executive Officer (retiring)
- Wesley Johnson, Director
- Eileen Auen, Director
Popular executive movements at AngioDynamics
- James Clemmer, who is President and Chief Executive Officer will soon retire (posted on January 6 2026).
Create your alert
to follow the executive moves at AngioDynamics.
Medical Equipment
AngioDynamics has 1,244 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Siemens Healthineers (Germany).
Popular M&A news in Medical Equipment
- CVC Capital Partners has announced the acquisition of WillowWood (posted on June 18 2026).
- Spectrum Vascular has acquired Piccolo Medical (posted on June 17 2026).
- Medtronic has acquired Scientia Vascular (posted on June 14 2026).
Popular contacts in Medical Equipment
News
Press releases by AngioDynamics
- AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) - AngioDynamics
- AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - AngioDynamics
- AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect - AngioDynamics
- AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer - AngioDynamics
- AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability - AngioDynamics
- AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference - AngioDynamics
- AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026 - AngioDynamics
- AngioDynamics to Present at the Leerink Partners Global Healthcare Conference - AngioDynamics
- AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform - AngioDynamics
- AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance - AngioDynamics
- View more press releases Close
Social media about AngioDynamics
- AngioDynamics on Wikipedia, Google News & Yahoo Finance
- AngioDynamics on LinkedIn, X (Twitter) & YouTube
